Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zhangyanming tablets for presbyopia-induced visual fatigue
ChiCTR2300069401Phase 4Not yet recruiting
- Sponsor
- Eye Hospital of Wenzhou Medical University
- Start
- Feb 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of zhangyanming in presbyopia and asthenopia (2 arms), sponsored by Eye Hospital of Wenzhou Medical University. Primary endpoint: Visual fatigue symptom score. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
zhangyanming
03
Conditions
presbyopiaasthenopia
Beyond the preview
Go deeper on ChiCTR2300069401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069401.